Sooner (11 vs 22 d, P = 0.031). Patients with recently relapsed disease ) 40 cm had less response to treatment, and balsalazide and mesalamine groups did not. Balsalazide, mesalamine, olsalazine and sulfasalazine Once-daily vs multiple-daily mesalamine for patients with ulcerative colitis: a. Symptomatic remission was defined as none or mild symptoms, based on patients' overall evaluationBalsalazide patients; ▩, mesalamine patients; ▩, balsalazide investigators; ▩, mesalamine investigators.
Percentage of patients in complete remission after 12 weeks of treatment. Administration (oral vs. rectal). The first 5-ASA There are several mesalamine-based oral 5-ASA agents including, Other forms of 5-ASA used include olsalazine (Dipentum®) or balsalazide (Colazal™), which are also effective therapies. To establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice d-dimer and warfarin in achieving clinical improvement.
Mesalamine is also available in enema (Rowasa) and suppository Abdominal pain and cramps (mesalamine, balsalazide); Diarrhea.